Table 3.

Adverse events are probably related to the study drug.

Adverse Event	Grading
	I	II	III	IV	V
Infection			1 (3%)	1 (3%)
Metabolic		1 (3%)
Vascular		1 (3%)	3 (9%)
Liver	1 (3%)
Constitutional symptoms	1 (3%)